Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - COMPLETE GENOMICS INC | Financial_Report.xls |
| 10-Q - FORM 10-Q - COMPLETE GENOMICS INC | d338046d10q.htm |
| EX-10.4 - OFFER LETTER EMPLOYMENT AGREEMENT - COMPLETE GENOMICS INC | d338046dex104.htm |
| EX-31.2 - CERTIFICATION OF CFO, AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) - COMPLETE GENOMICS INC | d338046dex312.htm |
| EX-31.1 - CERTIFICATION OF CEO, AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) - COMPLETE GENOMICS INC | d338046dex311.htm |
| EX-32.2 - CERTIFICATION BY THE CFO, AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) - COMPLETE GENOMICS INC | d338046dex322.htm |
Exhibit 32.1
Certification of Chief Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Clifford A. Reid, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Complete Genomics, Inc. on Form 10-Q for the quarterly period ended March 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Complete Genomics, Inc.
| By: | /s/ Clifford A. Reid, Ph.D. | |||
| Name: Clifford A. Reid, Ph.D. | ||||
| Title: President and Chief Executive Officer | ||||
Date: May 9, 2012
A signed original of this written statement required by Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350), has been provided to Complete Genomics, Inc. and will be retained by Complete Genomics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Complete Genomics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.